Von Willebrand Disease: Clinical Trials

1 trial for Von Willebrand Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Von Willebrand Disease: new trials by email Literature Review of Von Willebrand Disease trials Research Report on Von Willebrand Disease

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease
Recombinant von Willebrand factor : recombinant FVIII (rVWF:rFVIII), Marketed plasma-derived VWF/FVIII concentrate - Von Willebrand Disease
Phase 1CompletedBaxalta now part of Shire322008-12-012021-05-03

Narrower conditions

von Willebrand Diseases (1)

Broader conditions

Blood Coagulation Disorders (1)  ·  Blood Coagulation Disorders, Inherited (1)  ·  Blood Platelet Disorders (1)  ·  Coagulation Protein Disorders (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hemorrhagic Disorders (1)

Sponsors

Baxalta now part of Shire (1)

Countries

Austria (1)  ·  Canada (1)  ·  Germany (1)  ·  Italy (1)  ·  United Kingdom (1)  ·  United States (1)

Results publications

PMID 23777763